
    
      Efficacy and Safety of Lobeglitazone versus Sitagliptin in inadequately controlled by
      Metformin alone Type 2 Diabetes mellitus Patients with Metabolic syndrome: 24-week,
      Multi-center, Randomized, Double-blind, Phase 4 Study.
    
  